Scientific and educational activities

Riva, E. et al. Landscape of Immune Cell States and Ecosystems in Patients with Myelodysplastic Syndrome to Refine Prognostic Assessment and Predict Treatment Response. a Study By i4MDS Consortium. Blood 144, 665 (2024).

ASH annual Congress, 2024, Oral Presentation

Sompairac, N. et al. Immune-based risk score derived from bulk and single-cell transcriptomics enhances prognostic stratification in MDS. Blood 146, 115 (2025).